These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

754 related items for PubMed ID: 25479121

  • 1. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
    Chittiboina P, Montgomery BK, Millo C, Herscovitch P, Lonser RR.
    J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
    [Abstract] [Full Text] [Related]

  • 2. CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing's disease.
    Boyle J, Patronas NJ, Smirniotopoulos J, Herscovitch P, Dieckman W, Millo C, Maric D, Chatain GP, Hayes CP, Benzo S, Scott G, Edwards N, Ray Chaudhury A, Lodish MB, Sharma S, Nieman LK, Stratakis CA, Lonser RR, Chittiboina P.
    Endocrine; 2019 Jul; 65(1):155-165. PubMed ID: 31062234
    [Abstract] [Full Text] [Related]

  • 3. Comparison of MRI techniques for detecting microadenomas in Cushing's disease.
    Grober Y, Grober H, Wintermark M, Jane JA, Oldfield EH.
    J Neurosurg; 2018 Apr; 128(4):1051-1057. PubMed ID: 28452619
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of composite methionine-positron emission tomography/3.0-tesla magnetic resonance imaging to detect the localization and extent of early-stage Cushing adenoma.
    Ikeda H, Abe T, Watanabe K.
    J Neurosurg; 2010 Apr; 112(4):750-5. PubMed ID: 19698042
    [Abstract] [Full Text] [Related]

  • 5. Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions.
    Seok H, Lee EY, Choe EY, Yang WI, Kim JY, Shin DY, Cho HJ, Kim TS, Yun MJ, Lee JD, Lee EJ, Lim SK, Rhee Y.
    Korean J Intern Med; 2013 Jan; 28(1):81-8. PubMed ID: 23346000
    [Abstract] [Full Text] [Related]

  • 6. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study.
    Wang H, Hou B, Lu L, Feng M, Zang J, Yao S, Feng F, Wang R, Li F, Zhu Z.
    J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202
    [Abstract] [Full Text] [Related]

  • 7. Potential utility of FLAIR in MRI-negative Cushing's disease.
    Chatain GP, Patronas N, Smirniotopoulos JG, Piazza M, Benzo S, Ray-Chaudhury A, Sharma S, Lodish M, Nieman L, Stratakis CA, Chittiboina P.
    J Neurosurg; 2018 Sep; 129(3):620-628. PubMed ID: 29027863
    [Abstract] [Full Text] [Related]

  • 8. Utility of 13N-Ammonia PET/CT to Detect Pituitary Tissue in Patients with Pituitary Adenomas.
    Wang Z, Mao Z, Zhang X, He D, Wang X, Du Q, Xiao Z, Zhu D, Zhu Y, Wang H.
    Acad Radiol; 2019 Sep; 26(9):1222-1228. PubMed ID: 30318288
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dexamethasone suppression for 18F-FDG PET/CT to localize ACTH-secreting pituitary tumors.
    Kim K, Kim DK, Moon JH, Kim EH, Kim SH, Ku CR, Lee EJ.
    Cancer Imaging; 2023 Sep 12; 23(1):85. PubMed ID: 37700359
    [Abstract] [Full Text] [Related]

  • 11. Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas.
    Feng Z, He D, Mao Z, Wang Z, Zhu Y, Zhang X, Wang H.
    Clin Nucl Med; 2016 Mar 12; 41(3):e130-4. PubMed ID: 26646998
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome.
    Koulouri O, Steuwe A, Gillett D, Hoole AC, Powlson AS, Donnelly NA, Burnet NG, Antoun NM, Cheow H, Mannion RJ, Pickard JD, Gurnell M.
    Eur J Endocrinol; 2015 Oct 12; 173(4):M107-20. PubMed ID: 26245763
    [Abstract] [Full Text] [Related]

  • 14. Clinical application of combination [11C]C-methionine and [13N]N-ammonia PET/CT in recurrent functional pituitary adenomas with negative MRI or [18F]F-FDG PET/CT.
    Wang Z, Feng Z, Zhu D, Wang X, Chen J, Zhu Y, Wang H.
    BMC Endocr Disord; 2024 Feb 05; 24(1):19. PubMed ID: 38311763
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.
    Testa RM, Albiger N, Occhi G, Sanguin F, Scanarini M, Berlucchi S, Gardiman MP, Carollo C, Mantero F, Scaroni C.
    Eur J Endocrinol; 2007 Feb 05; 156(2):241-8. PubMed ID: 17287414
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.